Botulinum toxin during pregnancy and breastfeeding: what do we actually know?
Pregnancy and the early months with a new baby often change how people think about elective aesthetic treatments. If you used botulinum toxin, sometimes described as a muscle-relaxant injection, before pregnancy, it is natural to ask whether treatment can continue.
The practical answer is straightforward during pregnancy: purely cosmetic treatment is generally postponed. During breastfeeding, the situation is more nuanced because newer studies have found either undetectable or only minute amounts of onabotulinumtoxinA in breast milk.
Even so, cosmetic treatment is elective. Decisions during pregnancy and breastfeeding should not be based on social-media anecdotes alone. The product used, dose, reason for treatment and individual medical history all matter.
How does botulinum toxin work?
Botulinum toxin is injected in very small amounts into selected muscles. It temporarily reduces nerve-to-muscle signalling, which can soften dynamic facial lines caused by repeated expression. In medical practice, botulinum toxin is also used for conditions including chronic migraine, muscle spasticity and excessive sweating.
Its effect is mainly local. However, limited systemic exposure does not by itself prove that treatment is safe in pregnancy or breastfeeding. Safety recommendations depend on the quality of available human data, and pregnancy data remain limited.
The indication also matters. A medically necessary treatment for severe symptoms may be assessed differently from an elective cosmetic treatment. In aesthetics, there is usually no urgency, which is why postponing treatment is often the most sensible and conservative option.
Botulinum toxin during pregnancy
Randomised studies in pregnant patients are rarely performed for ethical reasons. Most information therefore comes from inadvertent exposure, case series, registries and patients treated for medical conditions. Recent reviews have not identified a clear increase in fetal loss or congenital malformations compared with background rates.
That is reassuring, but the evidence is still too limited to establish elective cosmetic treatment as safe. There is no medical urgency to treat expression lines during pregnancy, so postponing cosmetic injections until after delivery is the usual approach.
Why caution is still recommended
Pregnancy changes circulation, fluid balance, inflammatory reactions and skin sensitivity. Facial volume and expression can also change temporarily. Even when a treatment is expected to act locally, the benefit of an elective cosmetic injection during pregnancy is usually limited. Aesthetic planning is often more accurate after delivery, when the face and daily rhythm have stabilised.
What about breastfeeding?
This is where the evidence has evolved most. LactMed, updated in July 2026, reports that after cosmetic facial doses of onabotulinumtoxinA the toxin was either not detectable or present only in minute amounts in breast milk. Observational reports involving mothers treated with onabotulinumtoxinA, including for chronic migraine, have not identified a consistent pattern of adverse effects in breastfed infants.
These findings are reassuring, but they mainly relate to onabotulinumtoxinA and to specific dose ranges. They cannot automatically be applied to every botulinum toxin product, dose or indication. For an elective cosmetic treatment, some patients may still prefer to wait until breastfeeding is complete.
What if treatment happened before you knew you were pregnant?
An accidental treatment shortly before a positive pregnancy test is not a reason to panic. Available observational data do not show a clear pattern of increased congenital malformations. Tell your obstetric clinician the date of treatment, the product used and, if known, the dose. Further elective cosmetic sessions are usually postponed for the remainder of pregnancy.
If possible, keep a short record of the treatment date, treated areas, product name and approximate dose. This makes the conversation with your obstetric team more precise and often reduces anxiety.
Are dermal fillers or microneedling safe alternatives?
Not necessarily. Hyaluronic acid is naturally present in the body, but that does not make elective filler injections proven safe during pregnancy. Injections can still cause infection, swelling, vascular complications or require additional treatment if a complication occurs.
Microneedling also deliberately disrupts the skin barrier. For a cosmetic indication, the benefit during pregnancy is usually modest, while irritation, pigment change or infection can occur.
What can you focus on instead?
A simple, pregnancy-appropriate skincare routine is often the best option: broad-spectrum sun protection, gentle cleansing and adequate moisturisation. Some active ingredients are not suitable during pregnancy; retinoids, for example, should be avoided.
When is treatment reasonable again?
There is no single perfect date after birth or breastfeeding. The right moment depends on recovery, sleep, skin condition, feeding plans and personal preference. A consultation can help decide whether botulinum toxin, skin-quality treatment, gentle facials or simply a revised home-care routine is the most appropriate next step.
Conclusion
Cosmetic botulinum toxin treatment is generally postponed during pregnancy. During breastfeeding, the evidence is more nuanced, but treatment should still be discussed individually. At Divine Medica, consultation focuses on safety, timing and whether a treatment is genuinely appropriate at this stage of life.